# Oxonian Ventures

Oxonian Ventures is a Venture Capital based in Palo Alto, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Palo Alto, United States
- **Region:** North America
- **Address:** 380 Hamilton Avenue, Box 854, Palo Alto, CA 94302, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** www.oxonianventures.com
- **LinkedIn:** https://www.linkedin.com/company/oxonian-ventures

## Regulatory record

- **Reports private funds:** No

## About

Oxonian Ventures is the leading early-stage venture fund investing in companies founded by Oxford alumni, using investment capital from Oxford alumni and affiliated institutions. It has a portfolio of over 30+ companies and an all-alumni investment team. The firm invests in pre-seed, seed and Series A financings by companies founded by Oxford alumni and is now raising its third fund.

## Sectors

- BioTech
- MedTech
- FinTech
- AI/ML
- Semiconductors
- AgriTech & FoodTech
- ClimateTech
- Quantum Computing
- Material Science
- Privacy
- Data Analytics
- HRTech
- Education
- AdTech
- Entertainment Provider

## People

- Heather Preston — General Partner

## Questions

### How does Oxonian Ventures source proprietary deal flow?

The firm's sourcing is singular: it invests only in companies founded by University of Oxford alumni. Its capital comes exclusively from accredited investors who also studied at Oxford. This double-sided alumni filter creates an institutionalized warm-introduction network, with founders and investors often surfacing through overlapping university affiliations. The firm does not indicate a cold-outbound or broad market-screening model.

### Does Oxonian Ventures participate in fund commitments or only direct deals?

Available information describes only direct early-stage investments into Oxford-alumni-founded operating companies. The firm's website and portfolio pages show no disclosed allocation to external venture funds as a limited partner.

### What investment stages does Oxonian Ventures typically target?

The firm targets early-stage and seed-stage companies. Its portfolio includes pre-revenue biotech and quantum computing startups founded as recently as 2024 and 2025, alongside seed-stage fintech and consumer platforms. There is no disclosed allocation to growth equity or later-stage rounds.

## Related profiles

- [OXO Labs](https://altss.com/profile/oxo-group)
- [Oxshott Capital Partners](https://altss.com/profile/oxshott-capital-partners)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/oxonian-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology